The disease-fighting qualities of seaweed compounds are being investigated by an international network of scientists, with trials for new inhalation therapies for cystic fibrosis sufferers already underway.
Dr A Brancale and Dr A Westwell from PHRMY, joined up with Dr Clarkson, Senior lecturer in the School of Biosciences to develop small chemical inhibitors of the Bcl3 gene.
